Menveo

Medicinal product

(Invented) name

Menveo

Active substance (s)

Meningokokinio A grupės oligosacharidas/Meningokokinio C grupės oligosacharidas/Meningokokinio W-135 grupės oligosacharidas/Meningokokinio Y grupės oligosacharidas

Strength

10 µg/5 µg/5 µg/5 µg/0,5 ml

Pharmaceutical form

milteliai ir tirpalas injekciniam tirpalui

Route (s) of administration

leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07AH08, Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated

Marketing authorisation holder

GlaxoSmithKline Vaccines S.r.l., Italija

Date of authorisation

2010-03-15

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

One dose (0.5 ml of the reconstituted vaccine) contains:	0.5 ml
Meningokokinio A grupės oligosacharidas	10 µg
Meningokokinio C grupės oligosacharidas	5 µg
Meningokokinio W-135 grupės oligosacharidas	5 µg
Meningokokinio Y grupės oligosacharidas	5 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
50261	64138	1064138	flakonas	0,5 ml N5 (5 dozės) + N5	Receptinis	EU/1/10/614/002	Netiekiama	-	-	No	-	-
50262	64139	1064139	flakonas	0,5 ml N1 (1 dozė) + N1	Receptinis	EU/1/10/614/003	Netiekiama	-	-	No	-	-
107507	93612	1093612	flakonas	0,5 ml N10 (10 dozių) +N10	Receptinis	EU/1/10/614/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2010-03-15	Registruotas